Church & Dwight
NYSE: CHD
Stock price
101.32 USD
(+0%) TODAY
Financial Performance
5Y price score: 25
The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.
A score of 100 indicates that the stock did as well as the S&P 500 Index.
A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.
10Y return: 120.9%
US$ Per
Share
By default your notes are visible only to you.
81.3
52-week range
106.0
Your model inputs
Your fair value & Margin of safety
To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.
Forecast:
Valuation
Free Cash Flow Yield
4.6 %
Dividend Yield TTM
1.2 %
Market cap $
$ 24,007
Price / Earnings TTM
32.7
Price / Book TTM
5.5
PEG TTM
1.2
Earnings growth and return
LTM
5YR
10YR
Total return (price & dividends)
9.4 %
25.5 %
120.9 %
Free cash flow per share growth
13.1 %
26.6 %
119.6 %
Earnings per share growth
27.4 %
(3.2) %
96.1 %
Business Summary:
Latest Earnings Call Takeaways
2026 Q2 (Jul 31, 2026)
1) Strategy & Leadership
- Church & Dwight reported a strong Q2 2026, with CEO Rick Dierker highlighting the company's ability to outperform expectations despite a challenging environment.
- The company is focused on innovation and high-quality products, which have contributed to industry-leading organic sales growth.
- The acquisition of MISS MOUTH's, a leading stain remover brand, is expected to drive significant growth, with initial sales showing over 50% consumption growth since acquisition.
2) Financial & Segment Results
- Net sales increased by 1.6%, while organic sales grew by 5.8%, significantly above the expected 3%.
- Adjusted gross margin improved to 45.4%, up 40 basis points YoY, and adjusted EPS was $0.89, exceeding the outlook of $0.88.
- Domestic organic sales rose 5.1%, driven by strong performance in household and personal care segments, particularly from brands like THERABREATH and ARM & HAMMER.
- International sales grew 9.1%, with strong contributions from HERO and THERABREATH brands.
3) Problems / Headwinds
- The company faced inflationary pressures, particularly related to raw materials and transportation costs, which impacted gross margins by 400 basis points.
- Despite maintaining share in a competitive promotional environment, Church & Dwight noted that some competitors increased promotional activity significantly, which could affect future pricing strategies.
4) Operational or Product Plans
- Church & Dwight plans to continue investing in marketing, expecting marketing expenses to be at or above 11% of sales to support growth initiatives.
- New product launches are anticipated to contribute to about 50% of organic growth, with a focus on expanding the THERABREATH and HERO brands internationally.
- The company is optimistic about the future, with plans for further international M&A and innovation in existing categories.
5) Guidance & Outlook / Investor Angle
- The company raised its full-year organic sales growth outlook to 4% to 5%, up from 3% to 4%, and adjusted EPS growth outlook to 6% to 8%.
- Cash flow from operations is expected to reach approximately $1.175 billion, up from $1.15 billion.
- The management expressed confidence in the company's ability to navigate the current macroeconomic challenges and continue delivering strong results.
Bottom line: Church & Dwight's strong Q2 performance, driven by innovation and strategic acquisitions, positions the company favorably for continued growth despite inflationary pressures and competitive challenges. The raised guidance reflects confidence in operational fundamentals and market share expansion.
Annual Reports, Presentations And IR Contacts
Go to the websiteChurch & Dwight — Financial Overview, Stock Price, Market Cap
Church & Dwight is a company. Founded in 1847. As of August 14, 2026, the company's market capitalization is $24007166080 with a current stock price of $101.32.
